Torrent Pharma Q2 net drops a tad to Rs 204 cr as US biz shrinks 20%

Research and development spend during the Q2FY18 was Rs 107 crore as against Rs 111 crore during the same period last year

Ahmedabad-based Torrent Pharmaceuticals posted a marginal drop in profit after tax (PAT) to Rs 204 crore in the second quarter ending September 2017. from Rs 207 crore in the corresponding quarter last year as its US business shrank 20 per cent on a year-on-year basis. 

The company's revenues in Q2FY18 were flat at Rs 1,429 crore. The Ebitda came in at Rs 405 crore, up 9 per cent y-o-y.  

Torrent said in a statement in Ahmedabad, "Previous period includes exceptional revenues and profits, primarily on account of the launch of a new product in the US market, which had